Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India

Muthu, V; Agarwal, R; Rudramurthy, SM; Thangaraju, D; Shevkani, MR; Patel, AK; Shastri, PS; Tayade, A; Bhandari, S; Gella, V; Savio, J; Madan, S; Hallur, VK; Maturu, VN; Srinivasan, A; Sethuraman, N; Sibia, RPS; Pujari, S; Mehta, R; Singhal, T; Saxena, P; Gupta, V; Nagvekar, V; Prayag, P; Patel, D; Xess, I; Savaj, P; Panda, N; Rajagopal, GD; Parwani, RS; Patel, K; Deshmukh, A; Vyas, A; Sistla, SK; Padaki, PA; Ramar, D; Sarkar, S; Rachagulla, B; Vallandaramam, P; Premachandran, KP; Pawar, S; Gugale, P; Hosamani, P; Dutt, SN; Nair, S; Kalpakkam, H; Badhwar, S; Kompella, KK; Singla, N; Navlakhe, M; Prayag, A; Singh, G; Dhakecha, P; Chakrabarti, A

Agarwal, R (通讯作者),Postgrad Inst Med Educ & Res, Dept Pulm Med, Sect 12, Chandigarh 160012, India.

EMERGING INFECTIOUS DISEASES, 2023; 29 (1): 8

Abstract

We performed a case-control study across 25 hospitals in India for the period of January-June 2021 to evaluate the reasons for an COVID-19-associated ......

Full Text Link